CMBA
KDNY

C.M. Bidwell & Associates’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

C.M. Bidwell & Associates’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,490
Closed -$34.5K – 592
2023
Q1 		$34.5K Sell
1,490
-9,149
-86% -$212K 0.03% 325
2022
Q4 		$279K Hold
10,639
– – 0.22% 79
2022
Q3 		$209K Buy
10,639
+1,349
+15% +$26.5K 0.17% 105
2022
Q2 		$162K Buy
+9,290
New +$162K 0.13% 145